Speakers

Agenda

Registration

FAQ

Committees

Pricing

Life Science Future – MedTech Speakers

Learn more about the keynote speakers featured at

Life Sciences Future – MedTech 2021. 

 

 Stephanie Fertig

Stephanie Fertig

HHS Small Business Program Lead, SEED (Small business Education and Entrepreneurial Development), Office of Extramural Research (OER), National Institutes of Health (NIH)

The SEED and SBIR Programs – Latest Updates

Ms. Stephanie J. Fertig is the new HHS Small Business Program Lead in SEED (Small business Education and Entrepreneurial Development) at the National Institutes of Health (NIH). She currently oversees the Health and Human Services (HHS) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, which includes the NIH SBIR and STTR programs. The HHS SBIR and STTR programs are congressionally mandated set-aside programs that provide over $1.2 billion dollars per year to small business concerns. Prior to joining SEED, she managed the SBIR and STTR Programs at the National Institute of Neurological Disorders and Stroke (NINDS). During her over 15 years at NIH she has led the development and implementation of multiple programs focused on small businesses and translational research. Ms. Fertig has a Bachelor of Science degree in Chemistry with a major in Physics from the University of Virginia and a Master of Business Administration from the University of Maryland’s Robert H. Smith School of Business.

Valerie Asbury

Valerie Asbury

President & CEO, LifeScan

Accelerating Innovation During the Pandemic – Clarity and Connection to a Mission

LifeScan is a global leader in blood glucose monitoring innovation and digital health technology and is best known for its iconic OneTouch brand used by millions of consumers across 6 continents and 70 countries. LifeScan recently launched its OneTouch® store, offering subscription-based and live coaching services accessible through its industry leading OneTouch Reveal™ mobile app.

In her role as President and CEO, Valerie leads the organization in its mission: Deliver personalized health & wellness experiences that engage people with diabetes and related conditions to live their best lives.

Valerie helmed LifeScan’s transition from Johnson & Johnson to private equity ownership in 2018, and has expertise with all stages of company growth, from start up to divestiture and experience spanning virtually every sector of the healthcare industry. Her expertise has been honed over 30 years of cross-functional leadership in guiding healthcare organizations through change in complex and challenging environments.

Valerie was named one of the Top 25 Women Leaders in Medical Devices of 2021 by the Healthcare Technology Report for her deep knowledge of the medical technology industry and her innovative leadership skills.

Prior to leading LifeScan as an independent company, Valerie spent over 20 years with Johnson & Johnson, serving in various leadership roles of increasing responsibility across five different medical device and pharmaceutical divisions, including 10 years in the diabetes consumer medical device space, where she focused on strategic growth and talent development.

As a registered nurse, Valerie has a passion for volunteerism and serves on the boards of various
organizations. She earned a bachelor’s degree in nursing from Vanderbilt University and completed executive- level business, marketing, finance, and strategic management education programs at Xavier, Penn State, and Harvard.

Venk Varadan

Venk Varadan

Co-founder & CEO

Speaker session information coming soon

Venk is the co-founder and Chief Executive Officer of Nanowear, a New York and PA-based nanotechnology and A.I. driven remote diagnostic platform. Nanowear’s SimpleSense, launching with enterprise channels in July 2021, is the first and only remote diagnostic device and digital platform that simultaneously and time synchronously assesses the heart, lungs and upper vascular system. Transmitting and analyzing 100million+ data points of 85 clinical-grade biomarkers per patient per day, Nanowear’s SimpleSense enables physicians of all specialties (primary care, acute illnesses or procedure, and chronic disease) to understand the trending and the digital signatures of their patients while the patients are in the comfort of their own home
Before Nanowear, Venk spent ~7 years in Technology Investment Banking, focusing exclusively on venture-backed software and communications technology in which he successfully advised growth companies in over $3bn USD worth of transactions at UBS Investment Bank, Citadel Investment Group and Wells Fargo Securities in New York. Prior to his finance career, Venk spent ~ 3 years in product marketing and sales at Eli Lilly and Sanofi Aventis Pharmaceuticals in New York.
Venk received his Masters of Business Administration from Columbia University and his Bachelors of Science & Engineering from Duke University.

 

Questions?

Questions about the event?  Please contact lifesciencesfuturehelp@gmail.com.

610.947.6800
www.lifesciencespa.org
650 E. Swedesford Rd | Ste 190 Wayne PA | 19087